Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

2.0K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.0K
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

2.9K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.9K
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

1.5K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.5K
Necrosis01:16

Necrosis

6.1K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The recombinant spike S1 protein induces injury and inflammation in co-cultures of human alveolar epithelial cells and macrophages.

PloS one·2025
Same author

Predictive Role of Platelet and Inflammation Markers for Severe COVID-19 by Propensity Score Matching.

Clinical laboratory·2024
Same author

Effect of second booster vaccination on clinical outcomes of Omicron-variant breakthrough infection: A propensity score matching cohort study.

Heliyon·2024
Same author

Interactive effect of booster vaccination and vitamin D status on antibody production of Omicron variant-infected adults: A real-world cohort study.

The clinical respiratory journal·2023
Same author

Effect of vitamin D status on adult COVID-19 pneumonia induced by Delta variant: A longitudinal, real-world cohort study.

Frontiers in medicine·2023
Same author

Neuroinflammation with increased glymphatic flow in a murine model of decompression sickness.

Journal of neurophysiology·2023

Related Experiment Video

Updated: Dec 27, 2025

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining
07:32

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining

Published on: May 23, 2025

950

Deferoxamine deconditioning increases neuronal vulnerability to hemoglobin.

Denggao Peng1, Cindy Acon Chen1, Deepa Ruhela1

  • 1Department of Emergency Medicine, University of Maryland, School of Medicine, USA.

Experimental Cell Research
|March 1, 2020
PubMed
Summary

Deferoxamine (DFO) pretreatment can increase neuronal vulnerability to hemoglobin-induced injury. Withdrawing DFO during elevated iron or heme levels may be detrimental, potentially negating prior protective effects.

Keywords:
DeferoxamineIntracerebral hemorrhageIron chelatorNeuronal deathStrokeSubarachnoid hemorrhage

More Related Videos

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

1.7K
Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII
04:48

Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII

Published on: May 4, 2020

8.6K

Related Experiment Videos

Last Updated: Dec 27, 2025

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining
07:32

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining

Published on: May 23, 2025

950
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

1.7K
Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII
04:48

Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII

Published on: May 4, 2020

8.6K

Area of Science:

  • Neuroscience
  • Toxicology
  • Biochemistry

Background:

  • Deferoxamine (DFO) chelates iron, protecting against oxidative damage.
  • However, DFO may interfere with protective cellular responses to iron.

Purpose of the Study:

  • To investigate if DFO treatment and subsequent withdrawal increase neuronal vulnerability to hemoglobin.
  • To understand the mechanisms behind DFO's effects on neuronal iron handling and injury.

Main Methods:

  • Neuronal cultures were pretreated with DFO, followed by hemoglobin exposure.
  • Assessed neuronal loss, ferritin induction, heme oxygenase-1 expression, and nonheme iron levels.
  • Evaluated protective effects of exogenous apoferritin, continuous DFO, or antioxidants.

Main Results:

  • DFO pretreatment and washout significantly increased neuronal loss (3-4 fold) after hemoglobin exposure.
  • This correlated with reduced ferritin induction by hemoglobin.
  • Neuronal loss was prevented by apoferritin, continuous DFO, or antioxidants.

Conclusions:

  • DFO deconditions neurons, increasing vulnerability to heme-mediated injury upon withdrawal.
  • The timing and duration of DFO administration are critical for its net effect in conditions like CNS hemorrhage.
  • Withdrawing DFO when iron/heme levels are high may be harmful.